Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
Is a
Allocation Type
Randomized
0
Participating Facility
Intervention Model
Parallel Assignment
0
Interventional Trial Phase
Phase 2
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Placebo
0
SB-509
0
Intervention Type
Other
0
Biological
0
Last Updated
November 1, 2012
0
Masked Party
Investigator
0
Masking Type
Single
0
Primary Completion Date
2010
0
Trial Recruitment Size
91
0
Trial Sponsor
Clinical Trial Start Date
2007
0
Study Completion Date
2010
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderate to Severe Diabetic Neuropathy and Unmeasurable Nerve Conduction Velocity
0
Official Website
Find more entities like Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.